Rib-X Pharmaceuticals Garners $5,500,000 New Round

  • Feed Type
  • Date
    1/28/2011
  • Company Name
    Rib-X Pharmaceuticals
  • Mailing Address
    300 George Street New Haven, CT 06511
  • Company Description
    Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the 50S subunit of the ribosome, which performs an essential role in the fundamental process of protein synthesis.
  • Website
    http://www.rib-x.com
  • Transaction Type
    Debt
  • Transaction Amount
    $5,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount included options, warrants or other rights to acquire another security. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.